Press "Enter" to skip to content

New patent for Glaxo Grp drug BREO ELLIPTA

0
Copyright © DrugPatentWatch. Originally published at New patent for Glaxo Grp drug BREO ELLIPTA

Annual Drug Patent Expirations for BREO+ELLIPTA
Annual Drug Patent Expirations for BREO+ELLIPTA

Breo Ellipta is a drug marketed by Glaxo Grp Ltd and is included in one NDA. It is available from two suppliers. There are fourteen patents protecting this drug.

BREO ELLIPTA drug price trends.

Drug patent litigation for BREO ELLIPTA.

This drug has three hundred and fifty-seven patent family members in forty-two countries.

The generic ingredient in BREO ELLIPTA is fluticasone furoate; vilanterol trifenatate. Two suppliers are listed for this compound. Additional details are available on the fluticasone furoate; vilanterol trifenatate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Glaxo Grp drug BREO ELLIPTA
    DrugPatentWatch - Make Better Decisions